Key points are not available for this paper at this time.
Cancer immunotherapy has transformed cancer treatment by harnessing the immune system to recognize and eliminate cancer cells. Recent years have witnessed significant advancements in this field, including the development of immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, cancer vaccines, and adoptive cell therapy. These approaches have shown promising results in clinical trials, leading to improved outcomes for cancer patients. This paper provides an in-depth overview of recent advances in cancer immunotherapy, their clinical implications, challenges, and future directions.
Nallasamy et al. (Sat,) studied this question.